2021 Q1 Form 10-Q Financial Statement

#000155837021006038 Filed on May 06, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $6.806M $7.058M
YoY Change -3.57% 12.14%
Cost Of Revenue $6.159M $6.771M
YoY Change -9.04% 5.85%
Gross Profit $647.0K $287.0K
YoY Change 125.44% -378.88%
Gross Profit Margin 9.51% 4.07%
Selling, General & Admin $4.829M $3.141M
YoY Change 53.74% 26.95%
% of Gross Profit 746.37% 1094.43%
Research & Development $701.0K $960.0K
YoY Change -26.98% -60.84%
% of Gross Profit 108.35% 334.49%
Depreciation & Amortization $138.0K $156.0K
YoY Change -11.54% -46.4%
% of Gross Profit 21.33% 54.36%
Operating Expenses $5.818M $4.429M
YoY Change 31.36% -16.06%
Operating Profit -$5.171M -$4.142M
YoY Change 24.84% -23.0%
Interest Expense $7.000K $12.00K
YoY Change -41.67% 12.57%
% of Operating Profit
Other Income/Expense, Net $141.0K $152.0K
YoY Change -7.24% -95.4%
Pretax Income -$5.030M -$3.990M
YoY Change 26.07% 92.5%
Income Tax $0.00 $38.00K
% Of Pretax Income
Net Earnings -$5.030M -$4.029M
YoY Change 24.84% 94.36%
Net Earnings / Revenue -73.91% -57.08%
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share -$0.03 -$29.01K
COMMON SHARES
Basic Shares Outstanding 144.3M
Diluted Shares Outstanding 144.3M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.94M $33.99M
YoY Change -8.97% -34.44%
Cash & Equivalents $1.272M $719.0K
Short-Term Investments $29.67M $33.27M
Other Short-Term Assets $1.280M $922.0K
YoY Change 38.83% 4.08%
Inventory $2.137M $2.448M
Prepaid Expenses
Receivables $2.023M $1.132M
Other Receivables $0.00 $0.00
Total Short-Term Assets $36.38M $38.50M
YoY Change -5.49% -33.11%
LONG-TERM ASSETS
Property, Plant & Equipment $2.669M $3.701M
YoY Change -27.88% -9.57%
Goodwill
YoY Change
Intangibles $8.110M
YoY Change
Long-Term Investments $6.643M $8.096M
YoY Change -17.95% 33.47%
Other Assets
YoY Change
Total Long-Term Assets $23.30M $25.97M
YoY Change -10.29% 30.62%
TOTAL ASSETS
Total Short-Term Assets $36.38M $38.50M
Total Long-Term Assets $23.30M $25.97M
Total Assets $59.68M $64.46M
YoY Change -7.42% -16.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.572M $1.446M
YoY Change 8.71% -56.58%
Accrued Expenses $4.681M $2.931M
YoY Change 59.71% 72.62%
Deferred Revenue $0.00
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $295.0K $587.0K
YoY Change -49.74% -15.91%
Total Short-Term Liabilities $7.004M $5.035M
YoY Change 39.11% -18.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $292.0K
YoY Change -100.0% -65.65%
Other Long-Term Liabilities $187.0K $828.0K
YoY Change -77.42% 51.07%
Total Long-Term Liabilities $187.0K $1.120M
YoY Change -83.3% -19.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.004M $5.035M
Total Long-Term Liabilities $187.0K $1.120M
Total Liabilities $7.191M $6.155M
YoY Change 16.83% -19.12%
SHAREHOLDERS EQUITY
Retained Earnings -$150.4M
YoY Change
Common Stock $2.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $52.49M $58.31M
YoY Change
Total Liabilities & Shareholders Equity $59.68M $64.46M
YoY Change -7.42% -16.74%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$5.030M -$4.029M
YoY Change 24.84% 94.36%
Depreciation, Depletion And Amortization $138.0K $156.0K
YoY Change -11.54% -46.4%
Cash From Operating Activities -$3.911M -$4.662M
YoY Change -16.11% -0.42%
INVESTING ACTIVITIES
Capital Expenditures $100.0K -$111.0K
YoY Change -190.09% 1476.7%
Acquisitions
YoY Change
Other Investing Activities -$8.415M $5.007M
YoY Change -268.06% 7.15%
Cash From Investing Activities -$8.535M $4.896M
YoY Change -274.33% 4.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.69M 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -3.911M -4.662M
Cash From Investing Activities -8.535M 4.896M
Cash From Financing Activities 12.69M 0.000
Net Change In Cash 243.0K 234.0K
YoY Change 3.85% -1565.71%
FREE CASH FLOW
Cash From Operating Activities -$3.911M -$4.662M
Capital Expenditures $100.0K -$111.0K
Free Cash Flow -$4.011M -$4.551M
YoY Change -11.87% -2.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001347858
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NYSEAMER
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
152397501
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
139061690
CY2019 xxii Postemployment Benefit Period
PostemploymentBenefitPeriod
P42M
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-36338
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
22nd Century Group, Inc.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0468420
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
500 Seneca Street
CY2021Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 507
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Buffalo
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
14204
CY2021Q1 dei City Area Code
CityAreaCode
716
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
270-1523
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.00001 par value
CY2021Q1 dei Trading Symbol
TradingSymbol
XXII
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
152444163
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1272000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1029000
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
29671000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
21313000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2023000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2159000
CY2021Q1 us-gaap Inventory Net
InventoryNet
2137000
CY2020Q4 us-gaap Inventory Net
InventoryNet
2034000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1280000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1806000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
36383000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
28341000
CY2021Q1 xxii Machinery And Equipment Net
MachineryAndEquipmentNet
2487000
CY2020Q4 xxii Machinery And Equipment Net
MachineryAndEquipmentNet
2483000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
182000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
247000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2669000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2730000
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8110000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8211000
CY2021Q1 us-gaap Long Term Investments
LongTermInvestments
6643000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
6536000
CY2021Q1 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
5876000
CY2021Q1 us-gaap Notes Payable Current
NotesPayableCurrent
295000
CY2020Q4 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
5876000
CY2021Q1 xxii Assets Noncurrent Excluding Property Plant And Equipment Net
AssetsNoncurrentExcludingPropertyPlantAndEquipmentNet
20629000
CY2020Q4 xxii Assets Noncurrent Excluding Property Plant And Equipment Net
AssetsNoncurrentExcludingPropertyPlantAndEquipmentNet
20623000
CY2021Q1 us-gaap Assets
Assets
59681000
CY2020Q4 us-gaap Assets
Assets
51694000
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
539000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
182000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
247000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1572000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1116000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4681000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4830000
CY2021Q1 us-gaap Postemployment Benefits Liability Current
PostemploymentBenefitsLiabilityCurrent
274000
CY2020Q4 us-gaap Postemployment Benefits Liability Current
PostemploymentBenefitsLiabilityCurrent
339000
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
272000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
7004000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7343000
CY2021Q1 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
187000
CY2020Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
241000
CY2021Q1 us-gaap Liabilities
Liabilities
7191000
CY2020Q4 us-gaap Liabilities
Liabilities
7584000
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
152397501
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
139061690
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
2000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
202880000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
189439000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
42000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
74000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-150434000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-145404000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
52490000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
44110000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
59681000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51694000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6806000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7058000
CY2021Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
6159000
CY2020Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
6771000
CY2021Q1 xxii Gross Profit Excluding Depreciation
GrossProfitExcludingDepreciation
647000
CY2020Q1 xxii Gross Profit Excluding Depreciation
GrossProfitExcludingDepreciation
287000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4829000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3141000
CY2021Q1 us-gaap Depreciation
Depreciation
138000
CY2020Q1 us-gaap Depreciation
Depreciation
156000
CY2021Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
150000
CY2020Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
172000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
5818000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
4429000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5171000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4142000
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
36000
CY2020Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-445000
CY2020Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-3000
CY2021Q1 us-gaap Investment Income Net
InvestmentIncomeNet
112000
CY2020Q1 us-gaap Investment Income Net
InvestmentIncomeNet
612000
CY2021Q1 us-gaap Interest Expense
InterestExpense
7000
CY2020Q1 us-gaap Interest Expense
InterestExpense
12000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
141000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
152000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5030000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3990000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5030000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-4028000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-32000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-196000
CY2020Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-3000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-32000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-193000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5062000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4221000
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
144258000
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
138610000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
44110000
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1153000
CY2021Q1 xxii Stock Issued During Period Value Warrants Exercise
StockIssuedDuringPeriodValueWarrantsExercise
11782000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
507000
CY2021Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-32000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5030000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
52490000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
62050000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
481000
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-196000
CY2020Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
3000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-4028000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
58310000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-5030000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-4028000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
234000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1029000
CY2021Q1 xxii Amortization And Depreciation Excluding Amortization Of Intangibles
AmortizationAndDepreciationExcludingAmortizationOfIntangibles
226000
CY2020Q1 xxii Amortization And Depreciation Excluding Amortization Of Intangibles
AmortizationAndDepreciationExcludingAmortizationOfIntangibles
266000
CY2021Q1 xxii Amortization Of License Fees
AmortizationOfLicenseFees
62000
CY2020Q1 xxii Amortization Of License Fees
AmortizationOfLicenseFees
62000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
65000
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
71000
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
36000
CY2020Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-445000
CY2020Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-3000
CY2021Q1 us-gaap Accretion Expense
AccretionExpense
6000
CY2020Q1 us-gaap Accretion Expense
AccretionExpense
12000
CY2021Q1 xxii Accretion Income
AccretionIncome
45000
CY2020Q1 xxii Accretion Income
AccretionIncome
209000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
507000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
481000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-135000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
266000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
103000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
182000
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-526000
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
273000
CY2021Q1 xxii Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-66000
CY2020Q1 xxii Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-70000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
381000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-639000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-148000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-188000
CY2021Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-119000
CY2020Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-213000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-272000
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
66000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3911000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4662000
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
20000
CY2020Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
103000
CY2021Q1 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
100000
CY2020Q1 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
8000
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
4950000
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
11613000
CY2021Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
13365000
CY2020Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
6606000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8535000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4896000
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
246000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1153000
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11782000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12689000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
243000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
485000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1272000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
719000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
1000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
0
CY2021Q1 xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
29000
CY2020Q1 xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
88000
CY2021Q1 xxii Machinery And Equipment Additions Included In Accounts Payable
MachineryAndEquipmentAdditionsIncludedInAccountsPayable
43000
CY2020Q1 xxii Machinery And Equipment Additions Included In Accounts Payable
MachineryAndEquipmentAdditionsIncludedInAccountsPayable
0
CY2020Q1 xxii Right Of Use Assets And Corresponding Operating Lease Obligations
RightOfUseAssetsAndCorrespondingOperatingLeaseObligations
198000
CY2021Q1 xxii Number Of Subsidiaries
NumberOfSubsidiaries
3
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span><i style="font-style:italic;"> </i><b style="font-weight:bold;">-</b><i style="font-style:italic;"> </i>The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2021Q1 xxii Inventory Tobacco Leaf Gross
InventoryTobaccoLeafGross
703000
CY2020Q4 xxii Inventory Tobacco Leaf Gross
InventoryTobaccoLeafGross
821000
CY2021Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
229000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
171000
CY2021Q1 xxii Inventory Raw Materials Excluding Tobacco Leaf
InventoryRawMaterialsExcludingTobaccoLeaf
1305000
CY2020Q4 xxii Inventory Raw Materials Excluding Tobacco Leaf
InventoryRawMaterialsExcludingTobaccoLeaf
1142000
CY2021Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
100000
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
100000
CY2021Q1 us-gaap Inventory Net
InventoryNet
2137000
CY2020Q4 us-gaap Inventory Net
InventoryNet
2034000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2808000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2670000
CY2021Q1 xxii Machinery And Equipment Net
MachineryAndEquipmentNet
2487000
CY2020Q4 xxii Machinery And Equipment Net
MachineryAndEquipmentNet
2483000
CY2021Q1 us-gaap Depreciation
Depreciation
138000
CY2020Q1 us-gaap Depreciation
Depreciation
156000
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y9M18D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.044
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
176000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
9000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
185000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
182000
CY2021Q1 us-gaap Long Term Investments
LongTermInvestments
6643000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
6536000
CY2021Q1 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
5876000
CY2020Q4 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
5876000
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
11288000
CY2021Q1 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
36000
CY2021Q1 xxii Accreted Interest Income On Convertible Note Receivable
AccretedInterestIncomeOnConvertibleNoteReceivable
71000
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
11395000
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
18748000
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
42000
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
18790000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
23652000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
74000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
23726000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
7628000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
7670000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
11692000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
11753000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
11120000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
11120000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
11960000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
11973000
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
18748000
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
18790000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
23652000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
23726000
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8110000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8211000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
150000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
172000
CY2020Q2 xxii Directors And Officers Insurance Policy Term
DirectorsAndOfficersInsurancePolicyTerm
P1Y
CY2020Q2 xxii Directors And Officers Insurance Premium
DirectorsAndOfficersInsurancePremium
2744000
CY2020Q2 xxii Directors And Officers Insurance Premium Paid
DirectorsAndOfficersInsurancePremiumPaid
549000
CY2020Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2195000
CY2020Q2 us-gaap Debt Instrument Term
DebtInstrumentTerm
P9M
CY2020Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0319
CY2021Q1 xxii License Fees Payable Current
LicenseFeesPayableCurrent
295000
CY2020Q4 xxii License Fees Payable Current
LicenseFeesPayableCurrent
293000
CY2020Q4 xxii Directors And Officers Insurance Payable Current
DirectorsAndOfficersInsurancePayableCurrent
246000
CY2021Q1 us-gaap Notes Payable Current
NotesPayableCurrent
295000
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
539000
CY2020Q2 us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
306000
CY2019 us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
881000
CY2019Q4 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
771000
CY2021Q1 us-gaap Postemployment Benefits Liability Current
PostemploymentBenefitsLiabilityCurrent
274000
CY2021Q1 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
187000
CY2020Q4 us-gaap Postemployment Benefits Liability Current
PostemploymentBenefitsLiabilityCurrent
339000
CY2020Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
241000
CY2021Q1 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
11293211
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11782000
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11293211
CY2021Q1 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
11293211
CY2021Q1 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
1461000
CY2021Q1 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
1585000
CY2021Q1 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
1310000
CY2021Q1 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
1310000
CY2021Q1 xxii Contractual Obligation Due After Fourth Year
ContractualObligationDueAfterFourthYear
1510000
CY2021Q1 us-gaap Contractual Obligation
ContractualObligation
7176000
CY2019Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
3
CY2020Q1 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
3
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
5000000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
5000000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
5000000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
15000000
CY2021Q1 xxii Share Based Compensation Arrangement Plan Term
ShareBasedCompensationArrangementPlanTerm
P10Y
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1979059
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2938000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.85
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1995000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.20
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1234000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.85
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
216000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.67
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3483000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.21
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
3600000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6581000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.50
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
235000
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.10
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
846000
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.36
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
6000
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.76
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5964000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.59
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y3M18D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
7480000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5028000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.56
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y1M6D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
8144000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5030000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-4028000
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
144258000
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
138610000
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9447000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22068000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0054
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8792
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y1M2D
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
507000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
481000
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
7765000
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y4M24D
CY2021Q1 xxii Employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptionswithmilestonebasedvesting
Employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptionswithmilestonebasedvesting
637000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2021Q1 xxii Contract Asset Payment Period After Shipment
ContractAssetPaymentPeriodAfterShipment
P21D
CY2021Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
53000
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
349000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
272000
CY2021Q1 xxii Contract Asset Liability Net
ContractAssetLiabilityNet
53000
CY2020Q4 xxii Contract Asset Liability Net
ContractAssetLiabilityNet
77000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6806000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7058000

Files In Submission

Name View Source Status
0001558370-21-006038-index-headers.html Edgar Link pending
0001558370-21-006038-index.html Edgar Link pending
0001558370-21-006038.txt Edgar Link pending
0001558370-21-006038-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xxii-20210331.xsd Edgar Link pending
xxii-20210331x10q.htm Edgar Link pending
xxii-20210331x10q_htm.xml Edgar Link completed
xxii-20210331xex31d1.htm Edgar Link pending
xxii-20210331xex31d2.htm Edgar Link pending
xxii-20210331xex32d2.htm Edgar Link pending
xxii-20210331_cal.xml Edgar Link unprocessable
xxii-20210331_def.xml Edgar Link unprocessable
xxii-20210331_lab.xml Edgar Link unprocessable
xxii-20210331_pre.xml Edgar Link unprocessable